Sagimet Biosciences SGMT
NASDAQ SGMT
$9.94 +0.20 (+2.05%)
As of: Oct 21, 2026 · 2:59 PM EDT

Sagimet Biosciences (SGMT) Operating Margin (2023)

Updated

Sagimet Biosciences' Operating Margin came in at -1537.00% for FY2023.

Analysis

Sagimet Biosciences (SGMT) Operating Margin (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn 37.86%
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 20.57%
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn -133.21%
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 28.37%
10 Sagimet Biosciences 530.61 Mn -43.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -372.60%
API Access

Sagimet Biosciences Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=SGMT&period=max&api_key=YOUR_API_KEY